Recurrent hepatitis C virus infection after liver transplantation: Immunohistochemical assessment of the viral antigen (original) (raw)

Abstract

Background: The value of immunohistochemical methods to identify hepatitis C virus antigen (HCVAg) in liver tissue has not been established. We have evaluated the significance of HCVAg expression in livers of patients with transplants and recurrent hepatitis C virus (HCV) infection.Methods: Forty-two liver biopsy specimens from 32 liver-transplant recipients with recurrent HCV infection were tested for HCVAg using fluorescein isothiocyanate–labeled polyclonal, polyreactive human immunoglobulin. Histologic assessment of liver and quantitation of HCV RNA in sera were carried out in specimens obtained simultaneously with biopsies.Results: HCVAg was found in 33% of the liver specimens obtained during the first month after transplantation and in all liver specimens obtained between 1 and 18 months after transplantation. Amounts of the antigen were significantly greater in specimens obtained more than 1 month after transplantation. A statistically significant increase of the average HCV RNA level in serum was observed in samples tested after the first month after the transplantation, and some decrease in the HCV RNA level was found in those obtained between 6 and 18 months after transplantation. Larger amounts of HCVAg were observed in specimens corresponding to episodes of acute or chronic hepatitis than in those associated with minimal parenchymal evidence of rejection.Conclusions: Observations of HCVAg expression in liver biopsy specimens indicated that the presence of viral antigens in hepatocytes is a constant finding in specimens obtained 1 month or longer after transplantation. Although large amounts of HCVAg correlated with acute or chronic hepatitis, the nature of this association with the development of pathologic changes remains to be established.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (18)

  1. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992;103:317-322.
  2. Sallie R, Cohen AT, Tibbs CJ, Portmann BC, Rayner A, O'Grady JG, et al. Recurrence of hepatitis C following orthotopic liver transplantation: A polymerase chain reaction and histological study. J Hepatol 1994;21:536- 542.
  3. Chazouilleres O, Kim M, Combs C, Ferrell L, Bachetti P, Roberts J, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994;106: 994-999.
  4. Ferrell LD, Wright TL, Roberts J, Ascher N, Lake J. Hepatitis C viral infection in liver transplant recipients. Hepatology 1992;16:865-876.
  5. Gretch DR, Bacchi CE, Corey L, dela Rosa C, Lesniewski RR, Kowdley K, et al. Persistent hepatitis C virus infection after liver transplantation: Clinical and virologi- cal features. Hepatology 1995;22:1-9.
  6. Gane EJ, Naoumov NV, Qian KP, Mondelli MU, Maer- tens G, Portmann BC, et al. A longitudinal analysis of hepatitis C virus replication following liver transplanta- tion. Gastroenterology 1996;110:167-177.
  7. Greenson JK, Swoboda-Newman S, Merion RM, Frank TS. Histologic progression of recurrent hepatitis C in liver transplant allografts. Am J Surg Pathol 1996;20:731- 738.
  8. Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, et al. Influence of the genotypes of hepati- tis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995;108:1088- 1096.
  9. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334:815-820.
  10. Krawczynski K, Kuo G, Di Bisceglie A, Houghton M, Bradley DW. Blood-borne non-A, non-B hepatitis: Immu- nohistochemical identification of disease-and hepatitis C virus-associated antigen(s). Hepatology 1989;10: 581.
  11. Krawczynski K, Beach MJ, Bradley DW, Kuo G, Di Bisceglie AM, Houghton M, et al. Hepatitis C virus antigen in hepatocytes: Immunomorphologic detection and identification. Gastroenterology 1992;103:622-629.
  12. Hiramatsu N, Hayashi N, Haruna Y, Kasahara A, Fusa- moto H, Mori C, et al. Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. Hepatology 1992;16:306-311.
  13. Ballardini G, Groff P, Giostra F, Francesconi R, Miniero R, Ghetti S, et al. Hepatocellular codistribution of c100, c33, c22, and NS5 hepatitis C virus antigens detected by using immunopurified polyclonal spontaneous hu- man antibodies. Hepatology 1995;21:730-734.
  14. Di Bisceglie AM, Hoofnagle JH, Krawczynski K. Changes in hepatitis C virus antigen in liver with antiviral therapy. Gastroenterology 1993;105:858-862.
  15. Ishak KG, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
  16. Gonzalez-Peralta RP, Fang JWS, Davis GL, Gish RG, Kohara M, Mondelli MU, et al. Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis C. Dig Dis Sci 1995;40:2595-2601.
  17. Di Martino V, Saurini F, Samuel D, Gigou M, Dussaix E, Reynes M, et al. Long-term longitudinal study of intrahe- patic hepatitis C virus replication after liver transplanta- tion. Hepatology 1997;26:1343-1350.
  18. Schluger LK, Sheiner PA, Thung SN, Lau JY, Min A, Wolf DC, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996;23:971-976.